Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for ...
Hypertrophic cardiomyopathy is an inherited condition that affects up to 750,000 people in the United States. It often involves left ventricular outflow tract obstruction. Septal reduction therapies ...
SAN RAMON, Calif. and MAINZ, Germany, April 17, 2017 /PRNewswire/ -- BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results